- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06142747
Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons (SURE-TEND)
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Tendinopathic Tendons
The goal of this observational study is to test whether a new ultrasound method, called SUper Resolution ultrasound imaging of Erythrocytes (SURE), can image the small blood vessels found in tendons of persons with a tendon overuse injury (tendinopathy). The main questions it aims to answer are:
- Is the method sensitive enough to detect the smallest blood vessels
- What information about the blood flow can be obtained (flow velocity, pressure, shape of the vessels)
- Can the flow in an injured tendon be distinguished from that of a healthy one
Participants will receive a non-invasive ultrasound examination of their Achilles (heel) or patellar (knee) tendon, using an advanced high frequency research ultrasound system.
Researchers will compare participants with either an Achilles or patellar tendon overuse injury to participants with healthy tendons, to see if there are distinct differences in the blood vessels that could help diagnose and treat the injuries.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Studies have reported an enlargement of the microvascular network in human tendons with a chronic overuse injury (tendinopathy). Ingrowth of new vessels and accompanying nerves have been proposed to be the cause of painful symptoms in patients with tendinopathy. Doppler ultrasound is the most common imaging modality to clinically investigate tendon neovascularization. This measurement is clinically useful, but its sensitivity is limited, which means that no Doppler flow is visible in healthy tendons despite invasive techniques having shown the presence of such flow. The lack of sensitivity in Doppler ultrasound means that it is impossible to accurately follow the progression from the healthy state (with zero Doppler) to a chronic state (with detectable Doppler), as well as the reverse process during healing of the injury.
The present study is designed to evaluate an ultrasound method called Super-resolution ultrasound imaging of erythrocytes (SURE), which is a new imaging technique for visualization and quantification of the microvasculature of tissues. The method is built on a technique called super-resolution ultrasound imaging (SRI), where an ultrasound contrast agent is injected into the bloodstream and tracked inside the vessels to build an image of the microvasculature. With SURE, no contrast agent is needed; it relies only on standard ultrasound to track the erythrocytes and thereby avoid invasive procedures.
The aim of this study is to determine the applicability of the SURE technique to detecting microvascular flow changes with tendinopathy by quantifying flow parameters in SURE images of healthy and tendinopathic tissues.
The study is designed as a cross-sectional, single-center, diagnostic, case-control trial on participants who are either healthy or have had a tendinopathy in their Achilles or patellar tendon. A formal sample size estimate cannot be made since the SURE method has not been clinically applied before, the sample sizes are therefore based on our experience with other outcomes for this patient group.
The study-specific medical device consists of 2 main components: a scanner system and an ultrasound probe.
- The ultrasound scanner: Vantage 256™ scanner (Verasonics, Kirkland, Washington, USA).
- The probe: GE L8-18i-D transducer (GE Healthcare, Chicago, Illinois, USA).
Both components are marked for conformity within the European Union (CE). The entire system (including the probe and scanner system) would classify as a Class IIa medical device, but it has not gone through a notified body as the system is not intended for commercial use.
For measurements, the participant is placed on a bed and scanned with conventional ultrasound to locate the region of tendon injury (or the thickest part of the tendon for healthy participants) and characterize it with grey-scale and Doppler imaging. The region of interest is marked on the skin and the ultrasound probe is affixed to the tendon at the specified location using a custom holder to minimize motion. The probe is then be disconnected from the conventional ultrasound scanner and connected to the Vantage 256™ scanner to record SURE images. Image data may be collected for up to 1 minute. Two scans at the same location are used for estimating repeatability. The imaging setup and image processing will be adjusted to maximize quality of the SURE images. From the images, the vessel density, and potentially other parameters (flow rate, flow orientation, vessel dimensions etc.) may be determined.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rene B Svensson, PhD
- Phone Number: +45 38635870
- Email: rene.brueggebusch.svensson@regionh.dk
Study Contact Backup
- Name: Max FR Merkel, MSc
- Phone Number: +45 38635059
- Email: max.flemming.ravn.merkel@regionh.dk
Study Locations
-
-
-
Copenhagen, Denmark, 2400
- Recruiting
- Institute of Sports Medicine
-
Contact:
- Rene B Svensson, PhD
- Phone Number: +45 38635870
- Email: rene.brueggebusch.svensson@regionh.dk
-
Contact:
- Max FR Merkel, MSc
- Phone Number: +45 38635059
- Email: max.flemming.ravn.merkel@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Healthy participants:
Persons who have no self-reported current or historical injuries to the tendon and surrounding tissue, and display no symptoms of tendinopathy upon examination.
Participants with tendinopathy:
Persons who have no self-reported current or historical injuries to the tendon and surrounding tissue, aside from a uni- or bi-lateral tendinopathy of the patellar or Achilles tendon based on two clinical criteria: Tendon pain during physical activity and Tendon pain on local palpation.
Description
Inclusion Criteria:
- 18 to 70 years of age.
- BMI below 30.
- Able to lie still for 1 minute.
- Capable of providing signed informed consent.
Exclusion Criteria:
- Pregnancy.
- Dementia.
- Smoking.
- Diabetes.
- Arthritis.
- Current or historical injuries to the tendon or surrounding tissue aside from tendinopathy.
- Medical or surgical treatments for their tendinopathy that may influence blood flow.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control
Healthy Controls.
Super-Resolution Ultrasound Imaging of Erythrocytes (SURE) of both Achilles and Patellar Tendons.
|
Research ultrasound sequence for tracking erythrocytes and thereby generating a super-resolution image of the vasculature.
Other Names:
|
Tendinopathy Achilles
Patients with Achilles Tendinopathy.
Super-Resolution Ultrasound Imaging of Erythrocytes (SURE) of Achilles Tendons.
|
Research ultrasound sequence for tracking erythrocytes and thereby generating a super-resolution image of the vasculature.
Other Names:
|
Tendinopathy Patellar
Patients with Patellar Tendinopathy.
Super-Resolution Ultrasound Imaging of Erythrocytes (SURE) of Patellar Tendons.
|
Research ultrasound sequence for tracking erythrocytes and thereby generating a super-resolution image of the vasculature.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vessel density (all)
Time Frame: day 0 (the study is cross-sectional)
|
Mean difference in blood vessel density detected by SURE imaging, between the healthy and tendinopathic group (across both patellar and Achilles).
|
day 0 (the study is cross-sectional)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Repeatability (vessel density)
Time Frame: day 0 (the study is cross-sectional)
|
Intraclass correlation of blood vessel density detected by SURE imaging in repeated ultrasound scans of the same tendon across all participants.
|
day 0 (the study is cross-sectional)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vessel density (PT/AT)
Time Frame: day 0 (the study is cross-sectional)
|
Mean difference in blood vessel density detected by SURE imaging, between the healthy and tendinopathic group (within the patellar or Achilles individually).
|
day 0 (the study is cross-sectional)
|
Other quantifiable measures of microvasculature
Time Frame: day 0 (the study is cross-sectional)
|
To-be-defined quantitative image analysis outcome of the microvasculature (due to the novelty of the method, the exact image analysis pipeline is not yet defined)
|
day 0 (the study is cross-sectional)
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Michael Kjaer, PhD, University Hospital Bispebjerg and Frederiksberg
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BBH161
- 854796 (Other Grant/Funding Number: European Research Council: Synergy Grant)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tendinopathy
-
University of CadizRecruitingTendinopathy | Achilles Tendinopathy | Tendinopathy, Elbow | Patellar Tendinopathy | Tendinopathy Rotator CuffSpain
-
University of CalgarySport Science Association of Alberta (SSAA)UnknownAchilles Tendinopathy | Achilles Tendon Enthesopathy | Mid-Portion Achilles Tendinopathy | Insertional Achilles Tendinopathy | Non-Insertional Achilles TendinopathyCanada
-
Krankenhaus Barmherzige Schwestern LinzActive, not recruitingAchilles Tendinopathy | Insertional Achilles TendinopathyAustria
-
Guna S.p.aRecruitingTendinopathy | Achilles Tendinopathy | Insertional Achilles Tendinopathy | PeritendinitisItaly
-
Brooke Army Medical CenterRecruitingLateral Elbow TendinopathyUnited States
-
Elif Balevi BaturCompleted
-
Anika Therapeutics, Inc.Completed
-
University of DelawareRecruitingSever's Disease | Achilles Tendinopathy | Insertional Achilles Tendinopathy | Apophysitis; CalcaneusUnited States
-
Gelderse Vallei HospitalRecruiting
-
Maimonides UniversityRecruitingAchilles TendinopathyArgentina
Clinical Trials on Super-Resolution Ultrasound Imaging of Erythrocytes (SURE)
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitationHealthy | Chronic Kidney DiseasesUnited States
-
Centre Hospitalier National d'Ophtalmologie des...RecruitingStroke | Glaucoma | Hypertension | Diabetes | Retinal Degeneration | Macular Edema | Retinitis Pigmentosa | Retinal Detachment | Vascular Inflammation | Macular Dystrophy | Maculopathy, Age RelatedFrance
-
Exact ImagingCompletedProstate Cancer | Prostatic Neoplasm | Cancer of the PROSTATEUnited States
-
Peking University Third HospitalCompletedAcetabular Labrum TearChina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Cognitive/Functional Effects | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedBreast Carcinoma | Microcalcification
-
Oregon Health and Science UniversityUnknown
-
University of OuluOulu University Hospital; Kuopio University Hospital; University of Eastern FinlandCompletedKnee Osteoarthritis | Knee InjuriesFinland
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Argentina
-
Beijing Friendship HospitalBeijing Shuyi HospitalRecruitingMaintenance HemodialysisChina